CHAPTER 65 – Viral Hepatitis C

[1]  Jin Ye.  Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[3]  A. Moorman,et al.  Nonhospital Health CareAssociated Hepatitis B and C Virus Transmission: United States, 19982008 , 2009, Annals of Internal Medicine.

[4]  M. Alter,et al.  Epidemiology of hepatitis C virus infection. , 2007, World journal of gastroenterology.

[5]  M. Alter,et al.  Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature , 2007, Infection Control & Hospital Epidemiology.

[6]  S. Lewin,et al.  Immunopathogenesis of hepatitis B virus infection , 2007, Immunology and cell biology.

[7]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[8]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[9]  S. Lemon,et al.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Rockey,et al.  Noninvasive measures of liver fibrosis , 2006, Hepatology.

[11]  M. Alter,et al.  Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. , 2005, The Journal of infectious diseases.

[12]  J. Desenclos,et al.  [Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]. , 2005, Revue d'epidemiologie et de sante publique.

[13]  Christophe Combet,et al.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes , 2005, Hepatology.

[14]  L. Magder,et al.  Intrafamilial transmission of hepatitis C in Egypt , 2005, Hepatology.

[15]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[16]  M. Gale,et al.  Evasion of intracellular host defence by hepatitis C virus , 2005, Nature.

[17]  J. Pawlotsky,et al.  Use of virologic assays in the diagnosis and management of hepatitis C virus infection. , 2005, Clinics in liver disease.

[18]  R. Weber,et al.  Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Fraumeni,et al.  Hepatitis C Virus Infection, , 2022 .

[20]  J. Perz.  Estimated Global Prevalence of Hepatitis C Virus Infection , 2004 .

[21]  Y. Gilleece,et al.  Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? , 2004, Sexually Transmitted Infections.

[22]  J. Koskinas,et al.  Differences in epidemiology, liver disease and treatment response among HCV genotypes. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[23]  P. Marcellin,et al.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. , 2004, Annals of internal medicine.

[24]  Y. Hutin,et al.  The global burden of disease attributable to contaminated injections given in health care settings , 2004, International journal of STD & AIDS.

[25]  A. Craxì,et al.  When and how to treat acute hepatitis C? , 2003, Journal of hepatology.

[26]  Y. Hutin,et al.  Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates , 2003, BMJ : British Medical Journal.

[27]  J. Kaldor,et al.  Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. , 2003, International journal of epidemiology.

[28]  D. Cardo,et al.  Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. , 2003, American journal of infection control.

[29]  M. Alter,et al.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[30]  J. McHutchison,et al.  Current therapy for hepatitis C: pegylated interferon and ribavirin. , 2003, Clinics in liver disease.

[31]  M. Alter,et al.  Prevention of spread of hepatitis C , 2002, Hepatology.

[32]  E. Roberts,et al.  Maternal‐infant transmission of hepatitis C virus infection , 2002, Hepatology.

[33]  N. Terrault,et al.  Sexual activity as a risk factor for hepatitis C , 2002, Hepatology.

[34]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[35]  R. Bartenschlager,et al.  Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture , 2002, Journal of Virology.

[36]  S. Lemon,et al.  Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells , 2002, Journal of Virology.

[37]  H. Yoshizawa.  Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection in Japan: Projection to Other Countries in the Foreseeable Future , 2002, Oncology.

[38]  M. Kohara,et al.  Incident hepatitis C virus infection in a community‐based population in Japan , 2002, Journal of viral hepatitis.

[39]  R. Bartenschlager,et al.  Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication , 2001, Journal of Virology.

[40]  P. Lopalco,et al.  Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[41]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[42]  Chien-Jen Chen,et al.  Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors , 2001, Journal of medical virology.

[43]  S. Emerson,et al.  Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Abdel-hamid,et al.  Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence , 2000, Hepatology.

[45]  M. Intorcia,et al.  Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. , 2000, Journal of hepatology.

[46]  M. Manns,et al.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.

[47]  D. Thomas,et al.  Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  N. Zein.  Clinical Significance of Hepatitis C Virus Genotypes , 2000, Clinical Microbiology Reviews.

[49]  L. Magder,et al.  The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt , 2000, The Lancet.

[50]  H. Margolis,et al.  The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States , 2000, Hepatology.

[51]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[52]  A. Valleron,et al.  Modeling the hepatitis C virus epidemic in france , 1999, Hepatology.

[53]  Women,et al.  Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. , 1998, The Journal of infectious diseases.

[54]  M. Houghton,et al.  Effects of interferon treatment on the antiviral T‐cell response in hepatitis C virus genotype 1b‐ and genotype 2c‐infected patients , 1997, Hepatology.

[55]  A. Zanella,et al.  The incidence and risk factors of community‐acquired hepatitis C in a cohort of Italian blood donors , 1997, Hepatology.

[56]  E. Holmes,et al.  Population dynamics of flaviviruses revealed by molecular phylogenies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  G. Ippolito,et al.  Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. , 1995, American journal of infection control.

[58]  R. Purcell,et al.  Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.

[59]  C. Rice,et al.  Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses , 1994, Journal of virology.

[60]  A. Prince.  IMMUNITY IN HEPATITIS C VIRUS INFECTION , 1994, Vox sanguinis.

[61]  N. Kato,et al.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.

[62]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[63]  F. Callea,et al.  Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. , 2001, The Journal of infectious diseases.

[64]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[65]  H J Alter,et al.  Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.

[66]  M. Sata,et al.  Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. , 1997, Scandinavian journal of infectious diseases.